Cargando…
The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review
Allogeneic hematopoietic stem-cell transplantation (HSCT) is, at present, the only potentially curative therapy for myelofibrosis (MF). Despite many improvements, outcomes of HSCT are still burdened by substantial morbidity and high transplant-related mortality. Allogeneic transplant is generally co...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113188/ https://www.ncbi.nlm.nih.gov/pubmed/31534197 http://dx.doi.org/10.1038/s41409-019-0683-1 |